CYTOSORBENTS CORPORATION - COMMON STOCK
0.8200
24-April-24 15:00:23
15 minutes delayed
Stocks
-0.0590
-6.71%
Today's range
0.7900 - 0.8700
ISIN
N/A
Source
NASDAQ
-
CytoSorbents Reports Second Quarter 2023 Financial and Operational Results
01 Aug 2023 16:15:01 By Nasdaq GlobeNewswire
-
CytoSorbents to Report Second Quarter 2023 Operating and Financial Results
26 Jul 2023 07:00:00 By Nasdaq GlobeNewswire
-
CytoSorbents Appoints Alexander D’Amico as Chief Financial Officer
19 Jul 2023 07:00:00 By Nasdaq GlobeNewswire
-
CytoSorbents And Humedics Announce Theranostic Collaboration in the Field of Liver Disease
11 Jul 2023 07:00:00 By Nasdaq GlobeNewswire
-
CytoSorbents Completes Enrollment of the STAR-T Pivotal Trial
07 Jul 2023 07:07:00 By Nasdaq GlobeNewswire
-
15 Jun 2023 07:00:01 By Nasdaq GlobeNewswire
-
05 Jun 2023 09:00:00 By Nasdaq GlobeNewswire
-
CytoSorbents Reports First Quarter 2023 Results
02 May 2023 16:15:00 By Nasdaq GlobeNewswire
-
CytoSorbents to Report First Quarter 2023 Operating and Financial Results
26 Apr 2023 07:00:00 By Nasdaq GlobeNewswire
-
CytoSorbents’ Pivotal STAR-T Trial Reaches Second Key Milestone With 80 Patients Enrolled
20 Apr 2023 07:00:01 By Nasdaq GlobeNewswire
-
CytoSorbents Announces Board Chairman Al W. Kraus To Retire
19 Apr 2023 07:00:00 By Nasdaq GlobeNewswire
-
29 Mar 2023 08:30:00 By Nasdaq GlobeNewswire
-
22 Mar 2023 08:09:06 By Nasdaq GlobeNewswire
-
CytoSorbents Comments on Bank Exposure and Diversified Cash Position
14 Mar 2023 07:00:00 By Nasdaq GlobeNewswire
-
CytoSorbents Reports Fourth Quarter and Full Year 2022 Results
09 Mar 2023 16:15:00 By Nasdaq GlobeNewswire
-
07 Mar 2023 07:00:00 By Nasdaq GlobeNewswire